Thyroid Cancer Trial, Recruiting NCT06277180 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT06277180
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People who have been diagnosed with medullary thyroid cancer (a type of thyroid cancer) and whose doctors have assessed them as suitable for surgery — this includes both newly diagnosed cases and those who have had previous treatment
  • People whose doctors expect them to live for at least 12 weeks
  • People who do not have serious problems with major organs such as the heart, lungs, liver, or kidneys, and who do not have a severe or life-threatening infection
  • People who are willing and able to understand what the trial involves and sign a written consent form

Who may not be able to join:

  • People who have previously had an allergic reaction to imaging agents (substances used in medical scans)
  • People who cannot meet the sedation requirements for a PET-CT scan, or for whom a PET-CT scan is otherwise medically unsuitable (confirm with trial site)
  • People who are pregnant, breastfeeding, or planning to become pregnant or father a child during the course of the trial
  • People who are not suitable for surgery for reasons such as having no measurable disease, having a tumour that cannot be removed, or having cancer that has spread significantly to distant parts of the body — or people who decline surgery or decline the specific type of scan-guided surgery used in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0086-010-87787190

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

1-month post-surgery calcitonin level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov